The principal aim of the course is to provide a comprehensive and detailed understanding of the decision-making process for the management of all types and stages of skin cancer. This will include diagnosis and primary treatment, management of loco-regional disease and distant metastatic disease, and adjuvant treatment. This is particularly relevant given the rapid progress in our understanding of melanoma and non-melanoma skin cancer, and the development of new treatments. In particular delegates will acquire the following knowledge:
- Strategies for diagnosis of melanoma, Merkel cell and non-melanoma skin cancer including dermoscopy and confocal laser microscopy.
- The indications, risks and benefits and strategies for mole screening.
- Diagnosis of skin cancer: how to break bad news.
- The indications and methods for genetic diagnosis and genetic counseling of skin cancer patients.
- The present AJCC staging systems and how to stage melanoma, Merkel cell and cutaneous squamous cell carcinoma, and other non-melanoma skin cancers.
- The value of imaging and biomarkers for the detection of metastases and disease staging.
- Adjuvant treatment of skin cancer: radiotherapy; immunotherapy; chemotherapy.
- New systemic treatments for stage IV melanoma: targeted agents and immunotherapeutics.
- New treatment options of advanced basal cell carcinoma.
- New systemic treatments for advanced Merkel cell and squamous cell carcinoma.
- The characteristics of mucosal and uveal melanomas and their treatment options.
- Options for topical treatment of epithelial skin cancers.
- The current classification of cutaneous lymphoma; staging and treatment options for different subtypes of cutaneous lymphoma.
- Clinical trials in skin cancer: an update.
- The indications and strategies for supportive treatments including best supportive care.